Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Berchuck

Showing results (121-130 of 372) with videos related to

Pageof 38
Sort By:
Gynecologic Oncology|April 17, 2013
Timing of end-of-life care discussion with performance on end-of-life quality indicators in ovarian cancerMicael Lopez-Acevedo, Laura J Havrilesky, Gloria Broadwater, et al.
Gynecologic Oncology|August 11, 2007
The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancerAngeles Alvarez Secord, Laura J Havrilesky, Victoria Bae-Jump, et al.
SSM. Mental Health|July 29, 2025
Racial differences in the incidence of mental health illness among ovarian cancer patients: An analysis of SEER-Medicare dataFariha Rahman, Oyomoare L Osazuwa-Peters, Clare Meernik, et al.
Cancers|April 13, 2024
Racial Differences in Vaginal Fluid Metabolites and Association with Systemic Inflammation Markers among Ovarian Cancer Patients: A Pilot StudyOyomoare L Osazuwa-Peters, April Deveaux, Michael J Muehlbauer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 26, 2020
Management of high, moderate, and low penetrance ovarian cancer susceptibility mutations: an assessment of current risk reduction practicesCatherine H Watson, Lindsay Soo, Brittany A Davidson, et al.
Neoplasia (New York, N.Y.)|July 7, 2024
Metformin use and survival in people with ovarian cancer: A population-based cohort study from British Columbia, CanadaParamdeep Kaur, Andrew Berchuck, Anne Chase, et al.
Gynecologic Oncology|August 12, 2015
Prognostic significance of differential expression of angiogenic genes in women with high-grade serous ovarian carcinomaSharareh Siamakpour-Reihani, Kouros Owzar, Chen Jiang, et al.
Cancer|August 28, 2019
Patient preferences for attributes of primary surgical debulking versus neoadjuvant chemotherapy for treatment of newly diagnosed ovarian cancerLaura J Havrilesky, Jui-Chen Yang, Paula S Lee, et al.
Cell Reports|June 29, 2022
G6PD inhibition sensitizes ovarian cancer cells to oxidative stress in the metastatic omental microenvironmentShree Bose, Qiang Huang, Yunhan Ma, et al.
Gynecologic Oncology|October 24, 2007
Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositionsJohnathan M Lancaster, C Bethan Powell, Noah D Kauff, et al.
Pageof 38

Showing results (121-130 of 372) with videos related to

Sort By:
Pageof 38
Gynecologic Oncology|April 17, 2013
Timing of end-of-life care discussion with performance on end-of-life quality indicators in ovarian cancerMicael Lopez-Acevedo, Laura J Havrilesky, Gloria Broadwater, et al.
Gynecologic Oncology|August 11, 2007
The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancerAngeles Alvarez Secord, Laura J Havrilesky, Victoria Bae-Jump, et al.
SSM. Mental Health|July 29, 2025
Racial differences in the incidence of mental health illness among ovarian cancer patients: An analysis of SEER-Medicare dataFariha Rahman, Oyomoare L Osazuwa-Peters, Clare Meernik, et al.
Cancers|April 13, 2024
Racial Differences in Vaginal Fluid Metabolites and Association with Systemic Inflammation Markers among Ovarian Cancer Patients: A Pilot StudyOyomoare L Osazuwa-Peters, April Deveaux, Michael J Muehlbauer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 26, 2020
Management of high, moderate, and low penetrance ovarian cancer susceptibility mutations: an assessment of current risk reduction practicesCatherine H Watson, Lindsay Soo, Brittany A Davidson, et al.
Neoplasia (New York, N.Y.)|July 7, 2024
Metformin use and survival in people with ovarian cancer: A population-based cohort study from British Columbia, CanadaParamdeep Kaur, Andrew Berchuck, Anne Chase, et al.
Gynecologic Oncology|August 12, 2015
Prognostic significance of differential expression of angiogenic genes in women with high-grade serous ovarian carcinomaSharareh Siamakpour-Reihani, Kouros Owzar, Chen Jiang, et al.
Cancer|August 28, 2019
Patient preferences for attributes of primary surgical debulking versus neoadjuvant chemotherapy for treatment of newly diagnosed ovarian cancerLaura J Havrilesky, Jui-Chen Yang, Paula S Lee, et al.
Cell Reports|June 29, 2022
G6PD inhibition sensitizes ovarian cancer cells to oxidative stress in the metastatic omental microenvironmentShree Bose, Qiang Huang, Yunhan Ma, et al.
Gynecologic Oncology|October 24, 2007
Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositionsJohnathan M Lancaster, C Bethan Powell, Noah D Kauff, et al.
Pageof 38